TY - JOUR
T1 - Molecular pathogenesis and heterogeneity in type 3 VWD families in U.S. Zimmerman program
AU - the Zimmerman Program Investigators
AU - Christopherson, Pamela A.
AU - Haberichter, Sandra L.
AU - Flood, Veronica H.
AU - Perry, Crystal L.
AU - Sadler, Brooke E.
AU - Bellissimo, Daniel B.
AU - Di Paola, Jorge
AU - Montgomery, Robert R.
AU - Abshire, T.
AU - Weiler, H.
AU - Lillicrap, D.
AU - James, P.
AU - O’Donnell, J.
AU - Ng, C.
AU - Bennett, C.
AU - Sidonio, R.
AU - Manco-Johnson, M.
AU - Journeycake, J.
AU - Zia, A.
AU - Lusher, J.
AU - Rajpurkar, M.
AU - Shapiro, A.
AU - Lentz, S.
AU - Gill, J.
AU - Leissinger, C.
AU - Ragni, M.
AU - Tarantino, M.
AU - Roberts, J.
AU - Hord, J.
AU - Strouse, J.
AU - Ma, A.
AU - Valentino, L.
AU - Boggio, L.
AU - Sharathkumar, A.
AU - Gruppo, R.
AU - Kerlin, B.
AU - Kulkarni, R.
AU - Green, D.
AU - Hoots, K.
AU - Brown, D.
AU - Mahoney, D.
AU - Mathias, L.
AU - Bedros, A.
AU - Diamond, C.
AU - Neff, A.
AU - DiMichele, D.
AU - Giardina, P.
AU - Cohen, A.
AU - Paidas, M.
AU - Werner, E.
AU - Matsunaga, A.
AU - Shafer, F.
AU - Konkle, B.
AU - Cuker, A.
AU - Kouides, P.
AU - Stein, D.
N1 - Publisher Copyright:
© 2022 International Society on Thrombosis and Haemostasis.
PY - 2022/7
Y1 - 2022/7
N2 - Background: Type 3 von Willebrand Disease (VWD) is a rare and severe form of VWD characterized by the absence of von Willebrand factor (VWF). Objectives: As part of the Zimmerman Program, we sought to explore the molecular pathogenesis, correlate bleeding phenotype and severity, and determine the inheritance pattern found in type 3 VWD families. Patients/Methods: 62 index cases with a pre-existing diagnosis of type 3 VWD were analyzed. Central testing included FVIII, VWF:Ag, VWF:RCo, and VWFpp. Bleeding symptoms were quantified using the ISTH bleeding score. Genetic analysis included VWF sequencing, comparative genomic hybridization and predictive computational programs. Results: 75% of subjects (46) had central testing confirming type 3, while 25% were re-classified as type 1-Severe or type 1C. Candidate VWF variants were found in all subjects with 93% of expected alleles identified. The majority were null alleles including frameshift, nonsense, splice site, and large deletions, while 13% were missense variants. Additional studies on 119 family members, including 69 obligate carriers, revealed a wide range of heterogeneity in VWF levels and bleeding scores, even amongst those with the same variant. Co-dominant inheritance was present in 51% of families and recessive in 21%, however 28% were ambiguous. Conclusion: This report represents a large cohort of VWD families in the U.S. with extensive phenotypic and genotypic data. While co-dominant inheritance was seen in approximately 50% of families, this study highlights the complexity of VWF genetics due to the heterogeneity found in both VWF levels and bleeding tendencies amongst families with type 3 VWD.
AB - Background: Type 3 von Willebrand Disease (VWD) is a rare and severe form of VWD characterized by the absence of von Willebrand factor (VWF). Objectives: As part of the Zimmerman Program, we sought to explore the molecular pathogenesis, correlate bleeding phenotype and severity, and determine the inheritance pattern found in type 3 VWD families. Patients/Methods: 62 index cases with a pre-existing diagnosis of type 3 VWD were analyzed. Central testing included FVIII, VWF:Ag, VWF:RCo, and VWFpp. Bleeding symptoms were quantified using the ISTH bleeding score. Genetic analysis included VWF sequencing, comparative genomic hybridization and predictive computational programs. Results: 75% of subjects (46) had central testing confirming type 3, while 25% were re-classified as type 1-Severe or type 1C. Candidate VWF variants were found in all subjects with 93% of expected alleles identified. The majority were null alleles including frameshift, nonsense, splice site, and large deletions, while 13% were missense variants. Additional studies on 119 family members, including 69 obligate carriers, revealed a wide range of heterogeneity in VWF levels and bleeding scores, even amongst those with the same variant. Co-dominant inheritance was present in 51% of families and recessive in 21%, however 28% were ambiguous. Conclusion: This report represents a large cohort of VWD families in the U.S. with extensive phenotypic and genotypic data. While co-dominant inheritance was seen in approximately 50% of families, this study highlights the complexity of VWF genetics due to the heterogeneity found in both VWF levels and bleeding tendencies amongst families with type 3 VWD.
KW - bleeding
KW - genotype-phenotype association
KW - inherited blood coagulation disorders
KW - type 3 VWD
UR - http://www.scopus.com/inward/record.url?scp=85133103088&partnerID=8YFLogxK
U2 - 10.1111/jth.15713
DO - 10.1111/jth.15713
M3 - Article
C2 - 35343054
AN - SCOPUS:85133103088
SN - 1538-7933
VL - 20
SP - 1576
EP - 1588
JO - Journal of Thrombosis and Haemostasis
JF - Journal of Thrombosis and Haemostasis
IS - 7
ER -